ABIVAX |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.98 EUR | -0.57% |
|
-5.67% | +42.36% |
| 04-29 | Abivax: share price rises as two analysts express optimism | CF |
| 04-29 | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABIVAX | Other Biotechnology & Medical Research | -0.57% | -5.67% | +42.36% | -4.51% | +33.65% | 953M |  |  | |
- Stock Market
- Equities
- ABVX Stock
- Charts Abivax
- Relative Strength Chart
